We are actively tracking the number of publications by the scientific community which reference our structures, whether in the main text, figure captions or supplementary material. Selected articles are manually reviewed. Publications by SSGCID authors are excluded from the manually reviewed list. From our manual curation results, we estimate that the false positive rate might be as high as 50% for some structures.
This list was obtained from Google Scholar searches using an API provided by Christian Kreibich.
| Structure | Year released | #citations |
|---|---|---|
| 8T7W | 2023 | 0 |
| 8T7Z | 2023 | 0 |
| # | PDB | Additional SSGCID structures cited | Link | Title | Year | Citation | Highlighted abstract |
|---|---|---|---|---|---|---|---|
| 1 | 7jzl | - | https://www.nature.com/articles/s41598-025-12444-2 | Fusion of SARS-CoV-2 neutralizing LCB1 peptide with Bacillus amyloliquefaciens RNase improves antiviral efficacy | 2025 | NN Kostin, TV Bobik, EV Konovalova- Scientific Reports, 2025 - nature.com | structural interaction with the trimeric spike ( PDB : 7JZL ). Its in vivo efficacy has been demonstrated in multiple studies, including in transgenic mouse models 14 . Moreover, its compact |
| 2 | 7jzl | 7jzn | https://www.biorxiv.org/content/10.1101/2021.06.15.448568v1.abstract | Deep Mutational Scanning of Dynamic Interaction Networks in the SARS-CoV-2 Spike Protein Complexes: Allosteric Hotspots Control Functional Mimicry and | 2021 | G Verkhivker- bioRxiv, 2021 - biorxiv.org | pdb id 7KL9 (A), in the complex with the designed miniprotein binder LCB1, pdb id 7JZL (B) complex with the miniprotein LCB3, pdb id 7JZN (C). The structure is in ribbons with protomers A,B,C are colored in green, red and blue respectively |
| 3 | 7jzl | - | https://www.sciencedirect.com/science/article/pii/S0022283621003892 | A brief history of de novo protein design: minimal, rational, and computational | 2021 | DN Woolfson- Journal of Molecular Biology, 2021 - Elsevier | For comparison, the whole PDB is doubling in size approximately every 67 years. There are now over 100 structures of de novo peptides and proteins, which is a good resource ... Figure 2. A gallery of high-resolution de novo designed peptide and protein structures .. additional protein chains are shown in grey these are for protein fusions to the designs (6FES99) or with targeted protein-protein interactions (4OYD,5VID,6IWB,6XXV,7JZL,6YWC) |
| 4 | 7jzl | 7jzn | https://pubs.acs.org/doi/abs/10.1021/acs.jcim.1c00766 | Allosteric Control of Structural Mimicry and Mutational Escape in the SARS-CoV-2 Spike Protein Complexes with the ACE2 Decoys and Miniprotein Inhibitors: A | 2021 | GM Verkhivker, S Agajanian, DY Oztas- Journal of Chemical, 2021 - ACS Publications | Allosteric Control of Structural Mimicry and Mutational Escape in the SARS-CoV-2 Spike Protein Complexes with the ACE2 Decoys and Miniprotein Inhibitors: A Network-Based Approach for Mutational Profiling of Binding and Signaling |
| 5 | 7k43 | 7k4n | https://www.nature.com/articles/s41401-021-00851-w | Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19 | 2022 | C Wu, W Yin, Y Jiang, HE Xu- Acta Pharmacologica Sinica, 2022 - nature.com | on uncovering structures and functions for structural biology of SARS-CoV-2 and discuss important biological issues that remain to be addressed. We present the examples of structure - ... S2E12 (represented as a cyan surface) binds to the “up” conformation of SARS-CoV-2 S RBD (PDB: 7K4N); S2M11 (represented as a brown surface) binds to the “down” conformation of SARS-CoV-2 S RBD (PDB: 7K43); |
| 6 | 7k43 | 7k4n | https://pubs.acs.org/doi/abs/10.1021/acs.jpcb.1c00395 | Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies | 2021 | GM Verkhivker, L Di Paola- The Journal of Physical Chemistry B, 2021 - ACS Publications | Structural and biochemical studies of the severe acute respiratory syndrome (SARS)-CoV-2 spike glycoproteins and complexes with highly potent antibodies have revealed multiple conformation-dependen... |
| 7 | 7k43 | - | https://www.sciencedirect.com/science/article/pii/S2211124722005344 | Structures of Omicron spike complexes and implications for neutralizing antibody development | 2022 | H Guo, Y Gao, T Li, T Li, Y Lu, L Zheng, Y Liu, T Yang- Cell reports, 2022 - Elsevier | The recently reported structural model PDB entry 7T9K (Mannar et al., 2022) was used as an initial template for model building of the Omicron Spike trimer and ACE2. PDB entry 7K43 |
| 8 | 7k45 | - | https://www.nature.com/articles/S41591-021-01294-w | Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies | 2021 | RE Chen, X Zhang, JB Case, ES Winkler, Y Liu- Nature medicine, 2021 - nature.com | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly introduced antibody and vaccine countermeasures. Here, using monoclonal antibodies (mAbs), animal ... Structures of the SARS-CoV-2 RBD in complex with a representative neutralizing antibody from (a) class 1 (S2E12, PDB: 7K45), or (b) class 2 (S309, PDB: 6WPS). |
| 9 | 7k45 | - | https://www.science.org/doi/abs/10.1126/science.abm5835 | SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies | 2022 | SM Reincke, M Yuan, HC Kornau, VM Corman- Science, 2022 - science.org | structural basis of this public broadly reactive clonotype, we determined crystal structures of We compared the structures of CS44 and CV07-287 with other published VH1-58 antibodies... Structures of VH1-58 antibodies from other studies are shown for comparison, including COVOX-253 (PDB 7BEN), S2E12 (PDB 7K45), |
| 10 | 7k4n | - | https://www.nature.com/articles/s41564-021-00972-2 | Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail | 2021 | J Dong, SJ Zost, AJ Greaney, TN Starr- Nature, 2021 - nature.com | Understanding the molecular basis for immune recognition of SARS-CoV-2 spike glycoprotein antigenic sites will inform the development of improved therapeutics. We determined the structures of two human monoclonal antibodiesAZD8895 and AZD1061which form the basis ... A comparison of the cryo-EM structure of S2E12 in complex with the S glycoprotein (PDB ID: 7K4N) suggests that the mAb S2E12 likely uses nearly identical antibody–RBD interactions as those of AZD8895 |